Open AccessAbstract 3170: AKT/mTOR pharmacologic inhibition sensitizes RAS/MAPK-activated neuroblastoma cells to MEK1/2 inhibitors
Author(s) -
Marielle E. Yohe,
Norris Lam,
Joshua T. Kowalczyk,
Carol J. Thiele
Publication year - 2018
Publication title -
cancer research
Language(s) - Uncategorized
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2018-3170
Subject(s) - pi3k/akt/mtor pathway , protein kinase b , mapk/erk pathway , cancer research , cell growth , chemistry , growth inhibition , neuroblastoma , pharmacology , cell culture , medicine , signal transduction , biology , biochemistry , genetics